Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Janux Therapeutics, Inc. | Director | Common Stock | 2.5K | $137K | $54.75 | Jun 26, 2024 | Direct |
Bicara Therapeutics Inc. | Director | Stock Option (Right to Buy) | 23.7K | Sep 12, 2024 | Direct | ||
Tyra Biosciences, Inc. | Director | Stock Option (Right to Buy) | 18.6K | May 29, 2024 | Direct | ||
Janux Therapeutics, Inc. | Director | Stock Option (right to buy) | 8.35K | Jun 26, 2024 | Direct | ||
DICE Therapeutics, Inc. | Director | Stock Option (right to buy Common Stock) | 0 | Aug 9, 2023 | Direct |